warrants
Applied DNA Prices $12M Public Stock, Warrant Offering
The company, which develops molecular diagnostics and manufactures DNA, closed a roughly $4.2 million registered direct stock offering earlier this year.
Progenity Enters $25M Private Placement
The company will issue units representing an aggregate of shares of common stock and warrants to purchase stock shares at an aggregate purchase price of $5.72.
OpGen Enters $25M Direct Offering Agreement
A single healthcare-focused investor will purchase 2.78 million shares of common stock, 5.55 million prefunded warrants, and an additional 4.17 million shares of common stock.
OpGen Prices $9.4M Stock, Warrant Offering
OpGen said it intends to use the proceeds of the offering to complete its acquisition of German molecular diagnostics firm Curetis, among other things.
OpGen Plans $10.4M Stock, Warrant Sale
The proceeds from the sale will go toward the planned acquisition of Curetis and to support the ongoing submission of its technology to US regulators.